Lamivudine
- Product NDC
- 10135-605
- 11-digit product format
- 101350605
- Labeler code
- 10135
- Product ID
- 10135-605_66559dc6-afcc-4f79-b94f-6f7fc7333175
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA203564
- Marketing category
- ANDA
- Marketing start
- 2016-02-01
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-605-71 | Lamivudine | 240 mL in 1 BOTTLE, PLASTIC | SOLUTION | 240 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-605 | LAMIVUDINE SOLUTION [MARLEX PHARMACEUTICALS INC] | 1 | Legacy NDC, 1 package rows | 20160210_253ca106-d120-4483-9e5c-41b164044c9d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 10135-605-71 | 10135060571 | 240 mL in 1 BOTTLE, PLASTIC | 240 ml | Historical |